COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,533 Articles (22,881 medRxiv, 8,652 bioRxiv)

Most recent first Previous |  Page 1517: Articles 15161-15170  | Next

COVID-19 vaccine uptake in United States counties: geospatial vaccination patterns and trajectories towards herd immunity
Chernyavskiy, P., Richardson, J. W., Ratcliffe, S. J.
10.1101/2021.05.28.21257946 — Posted: 2021-05-31
The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis
Romero Starke, K., Reissig, D., Petereit-Haack, G., Schmauder, S., Nienhaus, A., Seidler, A.
10.1101/2021.05.27.21257909 — Posted: 2021-05-31
How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology
Waterlow, N. R., Van Leeuwen, E., Davies, N. G., CMMID COVID-19 working group, , Flasche, S., Eggo, R. M.
10.1101/2021.05.27.21257032 — Posted: 2021-05-31
Estimating the SARS-CoV-2 infected population fraction and the infection to-fatality ratio: A data-driven case study based on Swedish time series data
Wacker, A., Jöud, A., Bernhardsson, B., Gerlee, P., Gustafsson, F., Soltesz, K.
10.1101/2021.05.27.21257900 — Posted: 2021-05-31
The rapid reemergence of seasonal respiratory viruses in Houston, Texas, after relaxing COVID-19 restrictions
Hodjat, P., Christensen, P., Subedi, S., Olsen, R. J., Bernard, D. W., Long, S. W.
10.1101/2021.05.27.21257940 — Posted: 2021-05-30
Antibody Display of cell surface receptor Tetraspanin12 and SARS-CoV-2 spike protein
Hsieh, F.-L., Chang, T.-H.
10.1101/2021.05.29.446300 — Posted: 2021-05-30
Human genome integration of SARS-CoV-2 contradicted by long-read sequencing
Smits, N., Rasmussen, J., Bodea, G. O., Amarilla, A. A., Gerdes, P., Sanchez-Luque, F. J., Ajjikuttira, P., Modhiran, N., Liang, B., Faivre, J., Deveson, I. W., Khromykh, A. A., Watterson, D., Ewing, A. D., Faulkner, G. J.
10.1101/2021.05.28.446065 — Posted: 2021-05-30 Discussion: Onsite
Computational genomic analysis of the lung tissue microenvironment in COVID-19 patients
Bhuvaneshwar, K., Madhavan, S., Gusev, Y.
10.1101/2021.05.28.446250 — Posted: 2021-05-30
Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
Bhardwaj, T., Gadhave, K., Kapuganti, S. K., Kumar, P., Brotzakis, Z. F., Saumya, K. U., Nayak, N., Kumar, A., Garg, N., Vendruscolo, M., Giri, R.
10.1101/2021.05.29.446267 — Posted: 2021-05-30
Broadening a SARS-CoV-1 neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution
Zhao, F., Yuan, M., Keating, C., Shabaani, N., Limbo, O., Joyce, C., Woehl, J., Barman, S., Burns, A., Zhu, X., Ricciardi, M., Peng, L., Smith, J., Huang, D., Briney, B., Sok, D., Nemazee, D., Teiijaro, J., Wilson, I. A., Burton, D., Jardine, J. G.
10.1101/2021.05.29.443900 — Posted: 2021-05-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).